Aya Salama has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Human Labour of Data Work: Capturing Cultural Diversity through World Wide Dishes

    by Siobhan Mackenzie Hall, Samantha Dalal, Raesetje Sefala, Foutse Yuehgoh, Aisha Alaagib, Imane Hamzaoui, Shu Ishida, Jabez Magomere, Lauren Crais, Aya Salama, et al.

    This paper provides guidance for building and maintaining infrastructure for participatory AI efforts by sharing reflections on building World Wide Dishes (WWD), a bottom-up, community-led image and text dataset of culinary dishes and associated cultural customs. We present WWD as an example of participatory dataset creation, where community members both guide the design of the research process and contribute to the crowdsourced dataset. This approach incorporates localised expertise and knowledge to address the limitations of web-scraped Internet datasets acknowledged in the Participatory AI discourse. We show that our approach can result in curated, high-quality data that supports decentralised contributions from communities that do not typically contribute to datasets due to a variety of systemic factors. Our project demonstrates the importance of participatory mediators in supporting community engagement by identifying the kinds of labour they performed to make WWD possible. We surface three dimensions of labour performed by participatory mediators that are crucial for participatory dataset construction: building trust with community members, making participation accessible, and contextualising community values to support meaningful data collection. Drawing on our findings, we put forth five lessons for building infrastructure to support future participatory AI efforts.


  • Open Access

    The World Wide recipe: A community-centred framework for fine-grained data collection and regional bias operationalisation

    by Jabez Magomere, Shu Ishida, Tejumade Afonja, Aya Salama, Daniel Kochin, Yuehgoh Foutse, Imane Hamzaoui, Raesetje Sefala, Aisha Alaagib, Samantha Dalal, et al.


  • Open Access

    Novel Variants Linked to the Prodromal Stage of Parkinson’s Disease (PD) Patients

    by Marwa T. Badawy, Aya A. Salama, Mohamed Salama

    Background and objective: The symptoms of most neurodegenerative diseases, including Parkinson’s disease (PD), usually do not occur until substantial neuronal loss occurs. This makes the process of early diagnosis very challenging. Hence, this research used variant call format (VCF) analysis to detect variants and novel genes that could be used as prognostic indicators in the early diagnosis of prodromal PD. Materials and Methods: Data were obtained from the Parkinson’s Progression Markers Initiative (PPMI), and we analyzed prodromal patients with gVCF data collected in the 2021 cohort. A total of 304 participants were included, including 100 healthy controls, 146 prodromal genetic individuals, 21 prodromal hyposmia individuals, and 37 prodromal individuals with RBD. A pipeline was developed to process the samples from gVCF to reach variant annotation and pathway and disease association analysis. Results: Novel variant percentages were detected in the analyzed prodromal subgroups. The prodromal subgroup analysis revealed novel variations of 1.0%, 1.2%, 0.6%, 0.3%, 0.5%, and 0.4% for the genetic male, genetic female, hyposmia male, hyposmia female, RBD male, and RBD female groups, respectively. Interestingly, 12 potentially novel loci (MTF2, PIK3CA, ADD1, SYBU, IRS2, USP8, PIGL, FASN, MYLK2, USP25, EP300, and PPP6R2) that were recently detected in PD patients were detected in the prodromal stage of PD. Conclusions: Genetic biomarkers are crucial for the early detection of Parkinson’s disease and its prodromal stage. The novel PD genes detected in prodromal patients could aid in the use of gene biomarkers for early diagnosis of the prodromal stage without relying only on phenotypic traits.


  • Open Access

    Novel Variants Linked to the Prodromal Stage of Parkinson’s Disease (PD) Patients

    by Marwa T. Badawy, Aya Salama, Mohamed Salama

    Background and objective: Symptoms of most neurodegenerative diseases, including Parkinson’s disease (PD), usually do not occur until substantial neuronal loss occurs. This makes the process of early diagnosis very challenging. Hence, this research used variant call format (VCF) analysis to detect variants and novel genes that could be used as prognostic indicators in the early diagnosis of prodromal PD. Materials and Methods: Data were obtained from the Parkinson’s Progression Markers Initiative (PPMI), and we analyzed prodromal patients with gVCF data collected in the 2021 cohort. A total of 304 participants were included, including 100 healthy controls, 146 prodromal genetic individuals, 21 prodromal hyposmia individuals, and 37 prodromal RBDs. A pipeline was developed to process the samples from gVCF to reach variant annotation and pathway and disease association analysis. Results: Novel variant percentages were detected in the analyzed prodromal subgroups. The prodromal subgroup analysis revealed novel variations of 1.0%, 1.2%, 0.6%, 0.3%, 0.5%, and 0.4% for the genetic male, genetic female, hyposmia male, hyposmia female, RBD male, and RBD female, respectively. Interestingly, 12 potentially novel loci (MTF2, PIK3CA, ADD1, SYBU, IRS2, USP8, PIGL, FASN, MYLK2, USP25, EP300 and PPP6R2) that were recently detected in PD patients were detected in the prodromal stage of PD. Conclusion: Genetic biomarkers are crucial for the early detection of Parkinson’s disease and its prodromal stage. The novel PD genes detected in prodromal patients could aid in the use of gene biomarkers for early diagnosis of the prodromal stage without relying only on phenotypic traits.